---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-026888"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:22:22.610464+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals secures up to $16M senior secured debt from Anson Funds; settles Streeterville claims

## Summary
- Up to $16.3M principal in three tranches; first tranche $5.435M principal at $5M purchase price.
- Notes convertible at lower of $2.4168 or 92% of lowest VWAP; 6% interest, 15-month maturity.
- Warrants for 50% of principal/VWAP, 5-year term, exercise at $2.4168 with potential adjustments.
- Proceeds to fund 2024 NDA filings for NRX-100 (ketamine) and NRX-101; retire Streeterville debt.
- Streeterville settlement: $2.5M at closing plus $3.05M within 60 days; all claims released.

## SEC filing metadata
- accession: 0001437749-24-026888
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774924026888/0001437749-24-026888-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774924026888/nrxp20240813_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-026888
- JSON: https://secwatch.observer/filing/0001437749-24-026888.json
- Plain text: https://secwatch.observer/filing/0001437749-24-026888.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.